HIV/AIDS Clinical Trials Networks

The NIAID HIV/AIDS Clinical Trials Networks have been designed to address NIAID’s five HIV/AIDS scientific priorities

  1. Therapeutics for HIV/AIDS and HIV-associated infections in adults (including HIV cure, as well as co-occurring noninfectious and infectious diseases, including hepatitis and tuberculosis) (ACTG)
  2. HIV/AIDS and HIV-associated infections in children and mothers (IMPAACT)
  3. Integrated strategies to prevent HIV infection (HPTN)
  4. Vaccines to prevent HIV infection (HVTN)
  5. Microbicides to prevent HIV infection (MTN)

 

Content last reviewed on July 15, 2016